Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Valentin Ortiz-Maldonado"'
Autor:
Benno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, Linda Warmuth, Pere Barba, Matteo Doglio, David Henderson, Michael Hudecek, Andreas Kremer, Janet Markman, Magdalena Nauerth, Helene Negre, Carmen Sanges, Philipp B. Staber, Rebecca Tanzi, Julio Delgado, Dirk H. Busch, Jürgen Kuball, Maik Luu, Ulrich Jäger
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Lymphodepletion (LD) or conditioning is an essential step in the application of currently used autologous and allogeneic chimeric antigen receptor T-cell (CAR-T) therapies as it maximizes engraftment, efficacy and long-term survival of CAR-T. Its mai
Externí odkaz:
https://doaj.org/article/867d97eccd50488c8737f46f9637a5f0
Autor:
Nicolas Gazeau, Pere Barba, Gloria Iacoboni, Mi Kwon, Rebeca Bailen, Juan Luis Reguera, Lucía López-Corral, Rafael Hernani, Valentin Ortiz-Maldonado, Antonio Pérez-Martínez, Richard T Maziarz, Staci Williamson, Jessie Myers, Alexandria Hodges Dwinal, Eneida R. Nemecek, Mazyar Shadman, Andrew J. Cowan, Damian J. Green, Victor A. Chow, Alexandre V. Hirayama, David G. Maloney, Cameron J. Turtle, Jordan Gauthier
Publikováno v:
Transplantation and Cellular Therapy. 28:S185-S186
Autor:
Valentín Ortiz-Maldonado, Nuria Martinez-Cibrian, Marta Español-Rego, Guillermo Muñoz-Sanchez, Sergio Navarro, Leticia Alserawan, Maria Castella, Daniel Benitez-Ribas, Laura Magnano, Eva Gine, Luis Gerardo Rodríguez Lobato, Alexandra Martínez Roca, Helena Brillembourg, Mercedes Montoro, Pilar Ayora, Carlos Fernandez de Larrea, Mariona Pascal, Jordi Esteve, Avaro Urbano Ispizua, Manel Juan, Julio Delgado
Publikováno v:
HemaSphere, Vol 7, p e97357cb (2023)
Externí odkaz:
https://doaj.org/article/353b639924cd4a21aab34baf0da7e62d
Autor:
Nuria Martinez-Cibrian, Valentín Ortiz-Maldonado, Marta Español-Rego, Daniel Benitez-Ribas, Joan Cid, Miquel Lozano, Sergio Navarro, Laura Magnano, Eva Gine, Juan Gonzalo Correa Saldarriaga, Pablo Mozas, Luis Gerardo Rodríguez Lobato, Helena Brillembourg, Mercedes Montoro, Pilar Ayora, Leticia Alserawan, Alexandra Martínez Roca, Armando Lopez-Guillermo, Avaro Urbano Ispizua, Manel Juan, Mariona Pascal, Julio Delgado
Publikováno v:
HemaSphere, Vol 7, p e4838399 (2023)
Externí odkaz:
https://doaj.org/article/4cc0fa417f064bf2a92f41693b017ea0
Autor:
Nuria Martinez-Cibrian, Sergi Betriu, Valentín Ortiz-Maldonado, Daniel Esteban, Natalia Tovar, Ana Triguero Moreno, Leticia Alserawan, Mercedes Montoro, Anna Van Muyden, Maike Spoon, Margot Pont, Christian Jacques, Julio Delgado
Publikováno v:
HemaSphere, Vol 7, p e026794e (2023)
Externí odkaz:
https://doaj.org/article/7bb3c33ab7064174ba362a9b50e49254
Autor:
Paulus A. F. Geerts, Nils ’t Hart, Otto Visser, Valentín Ortiz‐Maldonado, Martine E. D. Chamuleau
Publikováno v:
Clinical Case Reports, Vol 11, Iss 6, Pp n/a-n/a (2023)
Key Clinical Message The prognosis of patients with relapsed or refractory (R/R) BL is poor with limited response to salvage therapy, especially for patients with early relapse (
Externí odkaz:
https://doaj.org/article/955cb60c26bc4129ba079e5a05fec98a
Autor:
Alvaro Urbano-Ispizua, Sara Fernández, Pedro Castro, Francesc Fernández-Avilés, Enric Carreras, Adrián Téllez, Valentín Ortiz-Maldonado, Carlos Fernández de Larrea, Julio Delgado, Olaf Penack, Ana Belen Moreno-Castaño, Helena Ventosa, Marta Palomo, Julia Martinez-Sanchez, Alex Ramos, J M Nicolás, Gines Escolar, Maribel Diaz-Ricart
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 4 (2023)
Background Chimeric antigen receptor (CAR)-T cell-based immunotherapy constitutes a revolutionary advance for treatment of relapsed/refractory hematological malignancies. Nevertheless, cytokine release and immune effector cell-associated neurotoxicit
Externí odkaz:
https://doaj.org/article/596812ed16e74fdfbda10735d5315b0e
Autor:
Nuria Martinez-Cibrian, Marta Español-Rego, Mariona Pascal, Julio Delgado, Valentín Ortiz-Maldonado
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chimeric antigen receptor T-cells targeting the CD19 antigen have achieved impressive results in patients with relapsed/refractory (R/R) B-cell malignancies, leading to their approval in the European Union and other jurisdictions. In Spain, the 100%
Externí odkaz:
https://doaj.org/article/1b4381fb80f14eb9b8ac5d72d310c398
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.